TIWARI, Bishal. FDA Approved Durvalumab for Limited-Stage Small Cell Lung Cancer. Nepalese Journal of Cancer, [S. l.], v. 9, n. 1, p. 9–14, 2025. DOI: 10.3126/njc.v9i1.77006. Disponível em: https://nepjol.info./index.php/njc/article/view/77006. Acesso em: 26 apr. 2025.